SM
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Complete response of a metastatic microsatellite-stable gastric cancer after neoadjuvant chemoimmunotherapy : should we still operate ? A case report and review of the literature | Frontiers in oncology | 2024 | 18 | 17 | |||
Cancer de l’œsophage : standards et innovations du traitement multidisciplinaire | Revue médicale suisse | 2023 | 66 | 51 | |||
Changes of health-related quality of life 6 months after high-risk oncological upper gastrointestinal and hepatobiliary surgery: a single-centre prospective observational study (ChangeQol Study) | BMJ open | 2023 | 116 | 93 | |||
Laparoscopic for advanced gastric cancer—minimally invasive for maximal results? | Translational gastroenterology and hepatology | 2022 | 358 | 69 | |||
Implementation and validation of a competency assessment tool for laparoscopic cholecystectomy | Surgical endoscopy and other interventional techniques | 2022 | 132 | 59 | |||
Severity of oEsophageal Anastomotic Leak in patients after oesophagectomy: the SEAL score | British journal of surgery | 2022 | 112 | 78 | |||
Assessment of predictors of early postoperative complications after primary robotically assisted Roux-en-Y gastric bypass: a multicenter, retrospective cohort study | Surgical endoscopy | 2022 | 143 | 57 | |||
Therapieoptionen beim oligometastasierten Magenkarzinom | Der Chirurg | 2021 | 283 | 114 | |||
Blood-based multi-cancer detection using a novel variant calling assay (DEEPGENTM): early clinical results | Cancers | 2021 | 199 | 68 | |||
Anastomotic leak following oesophagectomy: research priorities from an international Delphi consensus study | British journal of surgery | 2021 | 247 | 0 | |||
Impact of nonalcoholic steatohepatitis on the outcome of patients undergoing roux-en-y gastric bypass surgery: a propensity score-matched analysis | Obesity Surgery | 2021 | 187 | 76 | |||
Mortality from esophagectomy for esophageal cancer across low, middle, and high-income countries: An international cohort study | European journal of surgical oncology | 2021 | 231 | 0 | |||
Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma - the phase III "PREVENT"- (FLOT9) trial of the AIO /CAOGI /ACO | BMC cancer | 2021 | 291 | 67 | |||
Esophageal cancer surgery: review of complications and their management | Annals of the New York Academy of Sciences | 2020 | 197 | 1 | |||
S3-Leitlinie Magenkarzinom – Diagnostik und Therapie der Adenokarzinome des Magens und ösophagogastralen Übergangs | Der Chirurg | 2020 | 180 | 1 | |||
Quand référer un patient en vue d'un traitement chirurgical de l'obésité | Revue médicale suisse | 2020 | 360 | 176 | |||
Cancer de l'œsophage et de la jonction oesogastrique: prise en charge et traitement multidisciplinaire | Revue médicale suisse | 2020 | 439 | 275 | |||
RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV | BMC Cancer | 2020 | 176 | 69 | |||
Fit-for-discharge criteria after esophagectomy: an international expert delphi consensus | Diseases of the Esophagus | 2020 | 186 | 1 | |||
Current surgical treatment standards for esophageal and esophagogastric junction cancer | Annals of the New York Academy of Sciences | 2020 | 173 | 1 | |||
Incidence and grading of complications after gastrectomy for cancer using the GASTRODATA registry: a european retrospective observational study | Annals of Surgery | 2020 | 178 | 1 | |||
Development and Validation of a Predictive Model for Internal Hernia after Roux-en-Y Gastric Bypass in a Multicentric Retrospective Cohort: The Swirl, Weight Excess Loss, Liquid Score | Annals of Surgery | 2020 | 432 | 2 | |||
International Variation in Surgical Practices in Units Performing Oesophagectomy for Oesophageal Cancer: A Unit Survey from the Oesophago-Gastric Anastomosis Audit (OGAA) | World journal of surgery | 2019 | 315 | 13 | |||
Perioperative chemotherapy for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial | The Lancet | 2019 | 346 | 1 | |||
Minimal length of proximal resection margin in adenocarcinoma of the esophagogastric junction: a systematic review of the literature | Updates in Surgery | 2019 | 305 | 2 | |||
S3-Leitlinie Magenkarzinom – Diagnostik und Therapie der Adenokarzinome des Magens und des ösophagogastralen Übergangs | Zeitschrift für Gastroenterologie | 2019 | 343 | 0 | |||
Delay in initiation adjuvant S-1 monotherapy for gastric cancer: important prognostic factor | Translational Gastroenterology and Hepatology | 2019 | 276 | 129 | |||
The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma | European Journal of Cancer | 2019 | 232 | 1 | |||
S3-Leitlinie – Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus | Zeitschrift für Gastroenterologie | 2019 | 274 | 289 | |||
International consensus on a complications list after gastrectomy for cancer | Gastric cancer | 2019 | 264 | 0 | |||
Laparoscopic Surgery for Gastric Cancer: The European Point of View | Journal of Oncology | 2019 | 292 | 113 | |||
Neoadjuvant chemoradiation for patients with advanced oesophageal cancer - which response grading system best impacts prognostic discrimination? | Histopathology | 2019 | 370 | 1 | |||
The role of surgery in advanced disease for esophageal and junctional cancer | Best Practice & Research: Clinical Gastroenterology | 2018 | 305 | 1 | |||
Cancer de l'estomac : prise en charge et traitement multidisciplinaire | Revue médicale suisse | 2018 | 500 | 710 | |||
Perioperative chemotherapy with or without epidermal growth factor receptor blockade in unselected patients with locally advanced oesophagogastric adenocarcinoma: Randomized phase II study with advanced biomarker program of the German Cancer Society (AIO/CAO STO-0801) | European journal of cancer | 2018 | 244 | 0 | |||
Early esophageal cancer: the significance of surgery, endoscopy, and chemoradiation | Annals of the New York Academy of Sciences | 2018 | 304 | 0 | |||
Endoscopic resection with adjuvant chemo-radiotherapy for superficial esophageal squamous cell carcinoma: A critical review | Critical reviews in oncology/hematology | 2018 | 268 | 0 | |||
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in combination with standard of care chemotherapy in primarily untreated chemo naïve upper gi-adenocarcinomas with peritoneal seeding - a phase II/III trial of the AIO/CAOGI/ACO | Pleura and Peritoneum | 2018 | 326 | 226 | |||
Chirurgische Strategie bei Frühkarzinomen des Ösophagus | Der Chirurg | 2018 | 283 | 0 | |||
Multimodal treatment in locally advanced gastric cancer | Updates in Surgery | 2018 | 311 | 1 | |||
Die Fremdkörperingestion – eine seltene Ursache persistierender, unklarer abdomineller Schmerzen | Deutsche Medizinische Wochenschrift | 2018 | 291 | 0 | |||
Cancer of the gastroesophageal junction: a diagnosis, classification, and management review | Annals of the New York Academy of Sciences | 2018 | 321 | 0 | |||
Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival | Gastric cancer | 2017 | 95 | 57 | |||
Neoadjuvant chemotherapy or chemoradiation for patients with advanced adenocarcinoma of the oesophagus? A propensity score-matched study | European journal of surgical oncology | 2017 | 281 | 0 | |||
Gastric cancer treatment in the world: Germany | Translational Gastroenterology and Hepatology | 2017 | 565 | 1 | |||
Therapeutisches Vorgehen beim oligometastasierten Magen- und Ösophaguskarzinom | Der Chirurg | 2017 | 297 | 0 | |||
Impact of the Weekday of Surgery on Outcome in Gastric Cancer Patients who Underwent D2-Gastrectomy | World journal of surgery | 2017 | 125 | 0 | |||
Current and future treatment options for esophageal cancer in the elderly | Expert opinion on pharmacotherapy | 2017 | 307 | 0 | |||
Preoperative staging of nodal status in gastric cancer | Translational gastroenterology and hepatology | 2017 | 636 | 0 | |||
Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial | JAMA oncology | 2017 | 166 | 0 | |||
The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI | BMC cancer | 2017 | 322 | 78 | |||
Obstipation bei Patienten mit nicht-heilbarer Krebserkrankung: Empfehlungen der S3-Leitlinie Palliativmedizin | Deutsche medizinische Wochenschrift | 2016 | 255 | 0 | |||
Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference | Gastric cancer | 2016 | 163 | 73 | |||
Resektion beim fortgeschrittenen Adenokarzinom des Magens und des Ösophagus : Erweiterung der Indikation | Der Chirurg | 2016 | 231 | 0 | |||
Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma | Oncoimmunology | 2016 | 116 | 54 | |||
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial | Lancet. Oncology | 2016 | 271 | 0 | |||
Description and analysis of clinical pathways for oesophago-gastric adenocarcinoma, in 10 European countries (the EURECCA upper gastro intestinal group - European Registration of Cancer Care) | European journal of surgical oncology | 2016 | 148 | 0 | |||
Long-term quality of life after surgery for adenocarcinoma of the esophagogastric junction: extended gastrectomy or transthoracic esophagectomy? | Gastric cancer | 2016 | 118 | 72 |